Savara Inc. (NASDAQ: SVRA) announced that the European Medicines Agency has validated the company's marketing authorization application for MOLBREEVI in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE